Open-label Extension Study to Evaluate the Safety of USL255 in Patients With Refractory Partial-onset Seizures
Clinical trial NCT01191086 · COMPLETED
Trial details
- NCT number
- NCT01191086
- Sponsor
- Upsher-Smith Laboratories
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-10-01
- Primary completion
- 2014-05-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.